bioRxivBioinformaticsPreprint
Evaluating the analytical validity of mutation calling pipeline for tumor whole exome sequencing
Abstract
Detecting somatic mutations from the patients tumor tissues has the clinical impacts in medical decision making. Library preparation methods, sequencing platforms, read alignment tools and variant calling algorithms are the major factors to influence the data analysis results. Understanding the performance of the tool combinations of the somatic variant calling pipelines has become an important issue in the use of the whole exome sequences (WES) analysis in clinical actions. In this study, we selected four state-of-the-art sequence aligners including BWA, Bowtie2, DRAGMAP, DRAGEN aligner (DragenA) and HISAT2. For the variant callers, we chose GATK Mutect2, Sentieon TNscope, DRAGEN caller (DragenC) and DeepVariant. The benchmarking tumor whole exome sequencing data released from the FDA-led Sequencing and Quality Control Phase 2 (SEQC2) consortium was applied as the true positive variants to evaluate the overall performance. Multiple combinations of the aligners and variant callers were used to assess the variation detection capability. We measured the recall, precision and F1-score for each combination in both single nucleotide variants (SNVs) and short insertions and deletions (InDels) variant detections. We also evaluated their performances in different variant allele frequencies (VAFs) and the base pair length. The results showed that the top recall, precision and F1-score in the SNVs detection were generated by the combinations of BWA+DragenC(0.9629), Bowtie2+TNscope(0.9957) and DRAGMAP+DragenC(0.9646), respectively. In the InDels detection, BWA+DragenC(0.9546), Hisat2+TNscope(0.7519) and DragenA+DragenC(0.8081) outperformed the other combinations in the recall, precision and F1-Score, respectively. In addition, we found that the variant callers could bias the variant calling results. Finally, although some combinations yielded high accuracies of variant detection, but some variants still could not be detected by these outperformed combinations. The results of this study provided the vital information that no single combination could achieve superior results in detecting all the variants of the benchmarking dataset. In conclusion, applying both merged-based and ensemble-based variants detection approaches is encouraged to further detect variants comprehensively.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Performance Assessment of Variant Calling Pipelines using Human Whole Exome Sequencing and Simulated data
Manojkumar Kumaran, Umadevi Subramanian, Bharanidharan Devarajan·BMC BioinformaticsPeer-reviewed·Jun 17, 2019
- Evaluating discordant somatic calls across mutation discovery approaches to minimize false negative drug-resistant findings
Hsin-Fu Lin, Pei-Miao Chien, … Jacob Shujui Hsu·Journal of Molecular DiagnosticsPeer-reviewed·Jun 13, 2025
- Variant calling pipelines for whole exome sequencing in clinical context
Johanna Stepanian, Diego Saldaña, … Jorge Diaz·medRxiv·Oct 18, 2024
- Comparison of three variant callers for human whole genome sequencing
Anna Maria Supernat, Oskar Valdimar Vidarsson, … Tomasz Stokowy·Scientific ReportsPeer-reviewed·Dec 10, 2018
- Evaluation of somatic variant calling methods on high coverage tumour-only amplicon sequencing data in a clinical environment
Dhammapal Bharne, Daniel Gaston·bioRxiv·Apr 11, 2026
- Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants
Aziz Belkadi, Alexandre Bolze, … Laurent Abel·Proceedings of the National Academy of SciencesPeer-reviewed·Apr 28, 2015